Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Miscellaneous

This phase II trial studies how well acalabrutinib works in treating patients with chronic graft versus host disease. Acalabrutinib may be an effective treatment for graft-versus-host disease caused by a stem cell transplant.
Miscellaneous
II
Kitko, Carrie
NCT04198922
VICCCTT2122

Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.